SBFM CIK: 1402328

Sunshine Biopharma Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.83
FY22:
−5.25
FY23:
−8.78
FY24:
−12.5
FY25:
−5.33
millions USD
FY21:
0
FY22:
−14.6
FY23:
−0.66
FY24:
−1.98
FY25:
−0.84
Change from FY21 to FY25
millions USD
FY21:
2.90
FY22:
39.5
FY23:
3.43
FY24:
8.94
FY25:
4.75
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.83
FY22:
−5.44
FY23:
−8.86
FY24:
−14.2
FY25:
−5.51

All amounts in millions USD Data source:SEC EDGAR